Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-328.17%Return on Equity
VS
Market
Sector
Industry
History
$ 13.99Close
$ 8.81 - $ 20.45 52-Week Range
Ticker Information
Ticker
CVKDCompany Name
CADRENAL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCADRENAL THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CVKD - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 4.3M | $ -14.11M | -328.17% |
| 3/31/2025 | $ 6.11M | $ -12.83M | -209.93% |
| 12/31/2024 | $ 7.44M | $ -10.65M | -143.17% |
| 9/30/2024 | $ 3.41M | $ -7.61M | -222.96% |
| 6/30/2024 | $ 3.99M | $ -6.24M | -156.22% |
| 3/31/2024 | $ 6.19M | $ -4.85M | -78.27% |
| 12/31/2023 | $ 7.69M | $ -8.36M | -108.64% |
| 9/30/2023 | $ 8.75M | $ -12.22M | -139.75% |
| 6/30/2023 | $ 3.18M | $ -12.21M | -384.52% |
| 3/31/2023 | $ 4.07M | $ 0 | 0% |
Key Performance Insights, Last 5 Years
- CADRENAL THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, CADRENAL THERAPEUTICS INC's average ROE has been -196.85%.
- The median ROE for CADRENAL THERAPEUTICS INC during this period was -156.22%
- CADRENAL THERAPEUTICS INC reached its highest ROE over the past 5 years at -78.27%.
- The lowest ROE recorded by CADRENAL THERAPEUTICS INC in the same timeframe -384.52%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CADRENAL THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ -670.84K ]
(=) ROE [ 0% ] CVKD - Return on Equity, Last 5 years
-384.52%
Minimum
Jun 30, 2023
-78.27%
Maximum
Mar 31, 2024
-196.85%
Average
-156.22%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |